MedTrace Logo

Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence

NCT03180372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2019-12-04

No results posted yet for this study

Summary

This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 lasers for improvement of symptoms of urinary incontinence.

Conditions

Interventions

DEVICE

Hybrid Fractional Laser

Consecutive and coincident fractional 2940 nm and 1470 nm lasers

Sponsors & Collaborators

  • Sciton

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-19
Primary Completion
2019-08-30
Completion
2019-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03180372 on ClinicalTrials.gov